Abstract:Ravindranath et all recently reported the results of treatment for 12 children with acute myeloid leukemia (AML) and Down syndrome (DS) using a Pediatric Oncology Group (POG) AML protocol with 4 to 6 courses of high-dose cytarabine (Am-C) as postremission therapy. According to the report, children with DS and AML were characterized by a young age at diagnosis (120 months in 10 of 12) and a high incidence of acute megakaryoblastic leukemia (M7, 5 of 12). It was also noteworthy that children with DS had a superior eventfree survival when compared with children without DS (EFS at 4 years; loo%, 28% f 6.2%). We recently treated nine children with AML and DS (Table I). All of them were diagnosed as having M7 using platelet-specific monoclonal antibodies and the platelet peroxidase (PPO) reaction on electron microscopy? Three children received induction chemotherapy with Ara-C (100 mg/m*/d on days 1 to 7) and daunorubicin (25 mg/m2/d on days 6 and 7). Consolidation chemotherapy was 6 courses of the same regimen. One patient has remained in continuous complete remission (CR) for more than 5 years, one relapsed during consolidation chemotherapy, and one died of heart failure. Remission induction chemotherapy for the subsequent 6 children consisted of daunorubicin (25 mg/mz/d on days 1 and 2), Ara-C (100 mg/mz/d for 7 consecutive days), and etoposide ( 1 50 mg/ m2/d on days 3,4 , and 5). Consolidation chemotherapy was 6 courses of the Same regimen. All six children achieved CR and have remained in CR for 4 to 48 months. In 5 of the 6 children, chemotherapy has already been terminated. During the same period, two non-DS children with M7 were treated with the Same protocol, but both of them failed to achieve CR. Our results as well as the POG study suggest that AML in DS is highly responsive to chemotherapy that includes daunorubicin and Ara-C. Although Ravindranath et al emphasized the contribution of intensive postremission therapy with highdose Ara-C to improvement of the EFS, our results suggest that a less intensive Am-C dose schedule with etoposide is also useful for the treatment of AML in children with DS. The French-American-British phenotypes were different between the two studies, because all 9 children had M7 in our study and only 5 of 12 children were classified as M7 in the POG study. For the diagnosis of M7, leukemic cells are identified as being of the megakaryocytic lineage by the PPO reaction on electron microscopy or by monoclonal or polyclonal platelet-specific antibodies.’ Because immunologic cell marker studies were only performed in 5 of 12 children, the incidence of M7 might have been underestimated in the POG study.

The Structure and Host Entry of an Invertebrate Parvovirus.

Bipartite genome and structural organization of the parvovirus Acheta domesticus segmented densovirus

[Genomic Structure and Proteins Sequence Analysis of Full-Length of Segment A of Three Infections Bursal Disease Viruses].

Injury to the upper cervical spine: fracture versus congenital anomaly.

Imaging performance of a digital storage phosphor system.

Parvovirus Capsid Structures Required for Infection: Mutations Controlling Receptor Recognition and Protease Cleavages

The crystal structure of cricket paralysis virus: the first view of a new virus family

Near-atomic Structure of a Giant Virus

The Three-Dimensional Structure of Infectious Flacherie Virus Capsid Determined by Cryo-Electron Microscopy

Evolutionary and taxonomic implications of conserved structural motifs between picornaviruses and insect picorna-like viruses

Structural Characterization of Canine Minute Virus, Rat and Porcine Bocavirus

A closing word: critical care visitation.

Favorable treatment outcome in children with acute myeloid leukemia and Down syndrome.

Crystal Structure of Swine Vesicular Disease Virus and Implications for Host Adaptation

Crystal structure of the ATPase domain of porcine circovirus type 2 Rep protein

DESIGNING EVOLUTIONARY ALGORITHMS FOR DYNAMIC ENVIRONMENTS, by Ronald W. Morrison, Springer, 2004, xii + 148 pp., with index, ISBN 3-540-21231-0. 66 references. (Hardback £38.50)

Five-year experience with Chinese cobra (Naja atra)--related injuries in two acute hospitals in Hong Kong.

Mechanism of enterovirus VP0 maturation cleavage based on the structure of a stabilised assembly intermediate

Human Bocavirus Capsid Structure: Insights into the Structural Repertoire of the Parvoviridae

Structurally mapping the diverse phenotype of adeno-associated virus serotype 4

Structure of the T=13 capsid of infectious pancreatic necrosis virus (IPNV) - a salmonid birnavirus